|By Staff and viagra overnight Wire Reports|
|Wednesday, 21 November 2012 14:27|
Shares of the 10mg cialis stock reacted almost immediately to the order cheap cialis pre-market news and headed higher after analysts at Leerink Swann said the mexico viagra BASF/Pronova deal "is positive for AMRN since it sets a high floor value for Vascepa, which has superior clinical data and much stronger/longer patent protection so a larger market opportunity exists."
The firm made note of the fact that the cialis next day viagra non prescription BASF takeout transaction was at 3x 2011 sales.
"AMRN's current market cap of roughly $2Bn implies just $667MM peak sales for Vascepa at the same 3x multiple, which we believe is way too low given Lovaza sales reached around 1.3bn last year, with around a tenth of the potential market opportunity," the analyst said.
"One could argue that AMRN deserves a higher multiple as a pharmaceutical product, which would imply an even lower market appreciation for Vascepa peak revenues at present."
The Pronova takeover highlights the viagra sales in canada value for shares of the Dublin Ireland based biopharma and one day delivery cialis Amarin Corporation management has said repeatedly that it prefers a buyout as the path to commercialization of its anti-triglyceride drug Vascepa.
BioMedReports Synta Announces Ganetespib Into Phase 3 Extension Of AML LI-1 Study; Ignyta Announces Phase I/II Clinical Tria... http://t.co/PPbxqFxMyi